Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 4Terminated 2Recruiting 2Not yet recruiting 2Active not recruiting 2Unknown 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Myeloid 2Other hematologic neoplasm 1

Conditions

Myelodysplastic Syndromes 187Leukemia, Myeloid, Acute 159Myeloproliferative Disorders 83Leukemia, Myelogenous, Chronic, BCR-ABL Positive 72Precursor Cell Lymphoblastic Leukemia-Lymphoma 61Primary Myelofibrosis 54Leukemia, Myelomonocytic, Chronic 44Leukemia 35Polycythemia Vera 33Multiple Myeloma 30Hematologic Neoplasms 30Thrombocythemia, Essential 29Lymphoma, Non-Hodgkin 28Leukemia, Biphenotypic, Acute 25Hodgkin Disease 25Lymphoma 23Myelodysplastic-Myeloproliferative Diseases 18Leukemia, Lymphocytic, Chronic, B-Cell 18Leukemia, Myeloid, Chronic-Phase 14Blastic Plasmacytoid Dendritic Cell Neoplasm 14Neoplasms 13Burkitt Lymphoma 12Mastocytosis 11Leukemia, Myeloid 11Graft vs Host Disease 11Blast Crisis 11Anemia, Refractory, with Excess of Blasts 11Lymphoma, Follicular 10Anemia, Aplastic 10Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 8

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Recruiting × Polycythemia × Myeloid × Clear all
NCT07527221 2026-06-01

Safety and Tolerability of ZE74-0282 in Healthy Volunteers

Eilean Therapeutics

Phase 1 Recruiting
40 enrolled
MyeloidOther hematologic neoplasm

Polycythemia, Thrombocythemia, Essential, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Primary Myelofibrosis

NCT06421025 2025-11-21

POLYVISCO

Hospices Civils de Lyon

Recruiting
160 enrolled
Myeloid

Polycythemia, Polycythemia Vera, Thrombosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡